December 16, 2024
Medscape Medical News took a deep dive into the diabetes and endocrinology stories of 2024 to develop a list of the 10 most read — those […]
December 13, 2024
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Emcitate (tiratricol) for treating peripheral thyrotoxicosis in […]
December 11, 2024
The American Diabetes Association (ADA)’s Standards of Care — 2025 offer new guidance on broader use of continuous glucose monitoring (CGM), use of glucagon-like peptide 1 […]
December 9, 2024
TOPLINE: Bone material strength index (BMSi) values remain low in patients with Cushing syndrome even after 6 years in remission, despite having comparable bone mineral density […]
December 9, 2024
TOPLINE: Increased cutaneous carbonyl stress is linked to slower nerve conduction in patients with metabolically well-controlled, recent-onset type 2 diabetes (T2D) and can predict the development […]
December 6, 2024
TOPLINE: International paediatric type 1 diabetes (T1D) registry data show improvement from 2013 to 2022 in average A1c and the proportion of children with T1D meeting […]
December 6, 2024
TOPLINE: People with type 2 diabetes (T2D) die from infections at a higher rate than similar people without diabetes, and the overall burden appears greater than […]
December 6, 2024
TOPLINE: Patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) appear to have a very low incidence of nonarteritic anterior ischemic optic neuropathy (NAION) when […]
December 5, 2024
TOPLINE: Consuming five or more servings per week of dark chocolate is associated with a lower risk for type 2 diabetes (T2D) compared with infrequent or […]